Cambridge Investment Research Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,029
| Closed | -$250K | – | 3232 |
|
|
2023
Q2 | $250K | Buy |
6,029
+807
| +15% | +$33.5K | ﹤0.01% | 2693 |
|
|
2023
Q1 | $314K | Buy |
5,222
+165
| +3% | +$9.92K | ﹤0.01% | 2448 |
|
|
2022
Q4 | $371K | Sell |
5,057
-312
| -6% | -$22.9K | ﹤0.01% | 2264 |
|
|
2022
Q3 | $408K | Sell |
5,369
-24
| -0.4% | -$1.82K | ﹤0.01% | 2103 |
|
|
2022
Q2 | $375K | Sell |
5,393
-283
| -5% | -$19.7K | ﹤0.01% | 2183 |
|
|
2022
Q1 | $470K | Sell |
5,676
-78
| -1% | -$6.46K | ﹤0.01% | 2157 |
|
|
2021
Q4 | $432K | Buy |
5,754
+84
| +1% | +$6.31K | ﹤0.01% | 2227 |
|
|
2021
Q3 | $659K | Sell |
5,670
-30
| -0.5% | -$3.49K | ﹤0.01% | 1833 |
|
|
2021
Q2 | $1.26M | Sell |
5,700
-514
| -8% | -$114K | 0.01% | 1364 |
|
|
2021
Q1 | $821K | Sell |
6,214
-227
| -4% | -$30K | ﹤0.01% | 1569 |
|
|
2020
Q4 | $1.12M | Sell |
6,441
-693
| -10% | -$120K | 0.01% | 1233 |
|
|
2020
Q3 | $794K | Buy |
7,134
+449
| +7% | +$50K | 0.01% | 1321 |
|
|
2020
Q2 | $396K | Buy |
6,685
+417
| +7% | +$24.7K | ﹤0.01% | 1689 |
|
|
2020
Q1 | $422K | Buy |
6,268
+3,608
| +136% | +$243K | ﹤0.01% | 1467 |
|
|
2019
Q4 | $224K | Buy |
+2,660
| New | +$224K | ﹤0.01% | 2124 |
|